Nonthyroidal illness and the cardiorenal syndrome

Nature Reviews Nephrology

Volumn 9, Issue 10, 2013, Pages 599-609

  Meuwese, Christiaan L ^a   Dekkers, Olaf M ^a   Stenvinkel, Peter ^b   Dekker, Friedo W ^a   Carrero, Juan J ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; THYROID HORMONE; THYROXINE;

CARDIORENAL SYNDROME; HEART DISEASE; HEART FUNCTION; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MORTALITY; MULTIPLE ORGAN FAILURE; NONTHYROIDAL ILLNESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; THYROID DISEASE;

CARDIO-RENAL SYNDROME; HUMANS; KIDNEY; RISK FACTORS; THYROID GLAND; THYROID HORMONES;

EID: 84884669494     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2013.170     Document Type: Review

References (152)

1. Ronco, C. Cardio-renal syndromes: From foggy bottoms to sunny hills. Heart Fail. Rev. 16, 509-517 (2011
2. Smith, G. L. et al. Renal impairment and outcomes in heart failure: Systematic review and meta-analysis. J. Am. Coll. Cardiol. 47, 1987-1996 (2006
3. Bongartz, L. G. et al. The severe cardiorenal syndrome: 'Guyton revisited'. Eur. Heart J. 26, 11-17 (2005
4. Hamilton, M. A. Prevalence and clinical implications of abnormal thyroid hormone metabolism in advanced heart failure. Ann. Thorac. Surg. 56, S48-S52 (1993
5. Zoccali, C. et al. Low triiodothyronine: A new facet of inflammation in end-stage renal disease. J. Am. Soc. Nephrol. 16, 2789-2795 (2005
6. Spratt, D. I. et al. Physiological effects of nonthyroidal illness syndrome in patients after cardiac surgery. Am. J. Physiol. Endocrinol. Metab. 293, E310-E315 (2007
7. Iervasi, G. et al. Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch. Intern. Med. 167, 1526-1532 (2007
8. Gerdes, A. M. & Iervasi, G. Thyroid replacement therapy and heart failure. Circulation 122, 385-393 (2010
9. Zoccali, C. et al. Low triiodothyronine and survival in end-stage renal disease. Kidney Int. 70, 523-528 (2006
10. Carrero, J. J. et al. Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease. J. Intern. Med. 262, 690-701 (2007
11. Meuwese, C. L. et al. Baseline levels and trimestral variation of triiodothyronine and thyroxine and their association with mortality in maintenance hemodialysis patients. Clin. J. Am. Soc. Nephrol. 7, 131-138 (2012
12. Warner, M. H. & Beckett, G. J. Mechanisms behind the non-thyroidal illness syndrome: An update. J. Endocrinol. 205, 1-13 (2010
13. Peeters, R. P. et al. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J. Clin. Endocrinol. Metab. 88, 3202-3211 (2003
14. Docter, R., Krenning, E. P., de Jong, M. & Hennemann, G. The sick euthyroid syndrome: Changes in thyroid hormone serum parameters and hormone metabolism. Clin. Endocrinol. (Oxf.) 39, 499-518 (1993
15. Boelen, A., Kwakkel, J. & Fliers, E. Beyond low plasma T3: Local thyroid hormone metabolism during inflammation and infection. Endocr. Rev. 32, 670-693 (2011
16. Feingold, K. et al. Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response. Am. J. Physiol. Endocrinol. Metab. 286, E201-E207 (2004
17. Feingold, K. R. et al. LPS decreases fatty acid oxidation and nuclear hormone receptors in the kidney. J. Lipid Res. 49, 2179-2187 (2008
18. Squire, C. R. Methods for the investigation of thyroid function. Methods Mol. Biol. 324, 91-108 (2006
19. Song, S. H. et al. The prevalence of low triiodothyronine according to the stage of chronic kidney disease in subjects with a normal thyroid-stimulating hormone. Nephrol. Dial. Transplant. 24, 1534-1538 (2009
20. Kaptein, E. M. Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocr. Rev. 17, 45-63 (1996
21. Kaptein, E. M. et al. The thyroid in end-stage renal disease. Medicine (Baltimore) 67, 187-197 (1988
22. Yonemura, K. et al. Low free thyroxine concentrations and deficient nocturnal surge of thyroid-stimulating hormone in haemodialysed patients compared with undialysed patients. Nephrol. Dial. Transplant. 15, 668-672 (2000
23. Pagliacci, M. C. et al. Thyroid function tests in patients undergoing maintenance dialysis: Characterization of the 'low T4 syndrome' in subjects on regular hemodialysis and continuous ambulatory peritoneal dialysis. Nephron 46, 225-230 (1987
24. Lo, J. C., Chertow, G. M., Go, A. S. & Hsu, C. Y. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int. 67, 1047-1052 (2005
25. Ramirez, G., O'Neill, W. Jr, Jubiz, W. & Bloomer, H. A. Thyroid dysfunction in uremia: Evidence for thyroid and hypophyseal abnormalities. Ann. Intern. Med. 84, 672-676 (1976
26. Chen, W. L., Huang, W. S., Lin, Y. F. & Shieh, S. D. Changes in thyroid hormone metabolism in exertional heat stroke with or without acute renal failure. J. Clin. Endocrinol. Metab. 81, 625-629 (1996
27. Iglesias, P. et al. Thyroid function tests in acute kidney injury. J. Nephrol. 26, 164-172 (2013
28. Witzke, O. et al. Differential T4 degradation pathways in young patients with preterminal and terminal renal failure. Horm. Metab. Res. 39, 355-358 (2007
29. Meuwese, C. L., Stenvinkel, P., Dekker, F. W. & Carrero, J. J. Monitoring of inflammation in patients on dialysis: Forewarned is forearmed. Nat. Rev. Nephrol. 7, 166-176 (2011
30. Abo-Zenah, H. A., Shoeb, S. A., Sabry, A. A. & Ismail, H. A. Relating circulating thyroid hormone concentrations to serum interleukins 6 and 10 in association with non-thyroidal illnesses including chronic renal insufficiency. BMC Endocr. Disord. 8, 1 (2008
31. Zoccali, C. et al. Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease. J. Hypertens. 24, 2039-2046 (2006
32. Hermus, R. M. et al. Continuous infusion of interleukin 1β induces a nonthyroidal illness syndrome in the rat. Endocrinology 131, 2139-2146 (1992
33. Carrero, J. J. et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: A consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J. Ren. Nutr. 23, 77-90 (2013
34. Meuwese, C. L., Carrero, J. J. & Stenvinkel, P. Recent insights in inflammation-associated wasting in patients with chronic kidney disease. Contrib. Nephrol. 171, 120-126 (2011
35. Tomoda, F. et al. Effects of erythropoietin treatment on thyroid dysfunction in hemodialysis patients with renal anemia. Nephron 66, 307-311 (1994
36. Sato, K. et al. Reversible primary hypothyroidism and elevated serum iodine level in patients with renal dysfunction. Acta Endocrinol. (Copenh.) 126, 253-259 (1992
37. Wiederkehr, M. R., Kalogiros, J. & Krapf, R. Correction of metabolic acidosis improves thyroid and growth hormone axes in haemodialysis patients. Nephrol. Dial. Transplant. 19, 1190-1197 (2004
38. Wilber, J. F. & Utiger, R. D. The effect of glucocorticoids on thyrotropin secretion. J. Clin. Invest. 48, 2096-2103 (1969
39. Wiersinga, W. M. & Touber, J. L. The influence of β-adrenoceptor blocking agents on plasma thyroxine and triiodothyronine. J. Clin. Endocrinol. Metab. 45, 293-298 (1977
40. Singh, N., Weisler, S. L. & Hershman, J. M. The acute effect of calcium carbonate on the intestinal absorption of levothyroxine. Thyroid 11, 967-971 (2001
41. Napolitano, G. et al. Thyroid function and plasma selenium in chronic uremic patients on hemodialysis treatment. Biol. Trace Elem. Res. 55, 221-230 (1996
42. Carrero, J. J. et al. Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease. Nephrol. Dial. Transplant. 26, 184-190 (2011
43. Miyashita, K. et al. Regulation of rat liver type 1 iodothyronine deiodinase mRNA levels by testosterone. Mol. Cell Endocrinol. 115, 161-167 (1995
44. Iervasi, G. et al. Low T3 syndrome: A strong prognostic predictor of death in patients with heart disease. Circulation 107, 708-713 (2003
45. Psirropoulos, D. et al. Heart failure accompanied by sick euthyroid syndrome and exercise training. Curr. Opin. Cardiol. 17, 266-270 (2002
46. Opasich, C. et al. Sick euthyroid syndrome in patients with moderate to severe chronic heart failure. Eur. Heart J. 17, 1860-1866 (1996
47. Ascheim, D. D. & Hryniewicz, K. Thyroid hormone metabolism in patients with congestive heart failure: The low triiodothyronine state. Thyroid 12, 511-515 (2002
48. Hamilton, M. A., Stevenson, L. W., Luu, M. & Walden, J. A. Altered thyroid hormone metabolism in advanced heart failure. J. Am. Coll. Cardiol. 16, 91-95 (1990
49. Pingitore, A. et al. Early activation of an altered thyroid hormone profile in asymptomatic or mildly symptomatic idiopathic left ventricular dysfunction. J. Card. Fail. 12, 520-526 (2006
50. Pantos, C. et al. Thyroid hormone is a critical determinant of myocardial performance in patients with heart failure: Potential therapeutic implications. Eur. J. Endocrinol. 157, 515-520 (2007
51. Shanoudy, H. et al. Early manifestations of "sick euthyroid" syndrome in patients with compensated chronic heart failure. J. Card. Fail. 7, 146-152 (2001
52. Iltumur, K. et al. Clinical investigation: Thyroid function test abnormalities in cardiac arrest associated with acute coronary syndrome. Crit. Care 9, R416-R424 (2005
53. Karga, H. et al. The role of cytokines and cortisol in the non-thyroidal illness syndrome following acute myocardial infarction. Eur. J. Endocrinol. 142, 236-242 (2000
54. Wortsman, J., Premachandra, B. N., Chopra, I. J. & Murphy, J. E. Hypothyroxinemia in cardiac arrest. Arch. Intern. Med. 147, 245-248 (1987
55. Friberg, L., Werner, S., Eggertsen, G. & Ahnve, S. Rapid down-regulation of thyroid hormones in acute myocardial infarction: Is it cardioprotective in patients with angina? Arch. Intern. Med. 162, 1388-1394 (2002
56. Ross, R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340, 115-126 (1999
57. Torre-Amione, G. et al. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation 93, 704-711 (1996
58. Mancini, D. M. et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 85, 1364-1373 (1992
59. Adams, K. F. Jr et al. Prospective assessment of the occurrence of anemia in patients with heart failure: Results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry. Am. Heart J. 157, 926-932 (2009
60. Eskes, S. A. & Wiersinga, W. M. Amiodarone and thyroid. Best Pract. Res. Clin. Endocrinol. Metab. 23, 735-751 (2009
61. Stockigt, J. R. et al. Interaction of furosemide with serum thyroxine-binding sites: In vivo and in vitro studies and comparison with other inhibitors. J. Clin. Endocrinol. Metab. 60, 1025-1031 (1985
62. Simonides, W. S. et al. Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats. J. Clin. Invest. 118, 975-983 (2008
63. Wassen, F. W. et al. Induction of thyroid hormone-degrading deiodinase in cardiac hypertrophy and failure. Endocrinology 143, 2812-2815 (2002
64. Boelen, A. et al. Impaired bacterial clearance in type 3 deiodinase-deficient mice infected with Streptococcus pneumoniae. Endocrinology 150, 1984-1990 (2009
65. Ueta, C. B. et al. Absence of myocardial thyroid hormone inactivating deiodinase results in restrictive cardiomyopathy in mice. Mol. Endocrinol. 26, 809-818 (2012
66. Nomura, S. et al. Reduced peripheral conversion of thyroxine to triiodothyronine in patients with hepatic cirrhosis. J. Clin. Invest. 56, 643-652 (1975
67. de Jager, D. J. et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 302, 1782-1789 (2009
68. Katzeff, H. L., Powell, S. R. & Ojamaa, K. Alterations in cardiac contractility and gene expression during low T3 syndrome: Prevention with T3. Am. J. Physiol. 273, E951-E956 (1997
69. Sabatino, L. et al. A study of iodothyronine 5Ŷ-monodeiodinase activities in normal and pathological tissues in man and their comparison with activities in rat tissues. Life Sci. 68, 191-202 (2000
70. Bengel, F. M. et al. Effect of thyroid hormones on cardiac function, geometry, and oxidative metabolism assessed noninvasively by positron emission tomography and magnetic resonance imaging. J. Clin. Endocrinol. Metab. 85, 1822-1827 (2000
71. Amidi, M. et al. Effect of the thyroid state on myocardial contractility and ventricular ejection rate in man. Circulation 38, 229-239 (1968
72. Klein, I. & Ojamaa, K. Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 344, 501-509 (2001
73. Danzi, S. & Klein, I. Thyroid hormone-regulated cardiac gene expression and cardiovascular disease. Thyroid 12, 467-472 (2002
74. Danzi, S., Ojamaa, K. & Klein, I. Triiodothyronine-mediated myosin heavy chain gene transcription in the heart. Am. J. Physiol. Heart Circ. Physiol. 284, H2255-H2262 (2003
75. Bauab, R. C. et al. Low triiodothyronine (T3) or reverse triiodothyronine (rT3) syndrome modifies gene expression in rats with congestive heart failure. Endocr. Res. 31, 397-405 (2005
76. Moalic, J. M. et al. β1 adrenergic receptor and Gα s mRNAs in rat heart as a function of mechanical load and thyroxine intoxication. Cardiovasc. Res. 27, 231-237 (1993
77. Murray, J. F. & Kelly, J. J. Jr. The relation of thyroidal homone level to epinephrine response: A diagnostic test for hyperthyroidism. Ann. Intern. Med. 51, 309-321 (1959
78. Ojamaa, K., Klein, I., Sabet, A. & Steinberg, S. F. Changes in adenylyl cyclase isoforms as a mechanism for thyroid hormone modulation of cardiac β-adrenergic receptor responsiveness. Metabolism 49, 275-279 (2000
79. Jaroszynski, A. J. et al. Low T3 syndrome and signal-averaged ECG in haemodialysed patients. Physiol. Res. 54, 521-526 (2005
80. Fredlund, B. O. & Olsson, S. B. Long QT interval and ventricular tachycardia of "torsade de pointe" type in hypothyroidism. Acta Med. Scand. 213, 231-235 (1983
81. Shojaie, M. & Eshraghian, A. Primary hypothyroidism presenting with torsades de pointes type tachycardia: A case report. Cases J. 1, 298 (2008
82. Komar, N. N. & Gabrielsen, T. O. Arterial calcification in adult cretins. Am. J. Roentgenol. Radium. Ther. Nucl. Med. 101, 202-203 (1967
83. Meuwese, C. L. et al. Nonthyroidal illness: A risk factor for coronary calcification and arterial stiffness in patients undergoing peritoneal dialysis. J. Intern. Med. http://dx.doi.org/10.1111/joim.12107
84. Tatar, E. et al. Associations of triiodothyronine levels with carotid atherosclerosis and arterial stiffness in hemodialysis patients. Clin. J. Am. Soc. Nephrol. 6, 2240-2246 (2011
85. Tatar, E. et al. The association between thyroid hormones and arterial stiffness in peritoneal dialysis patients. Int. Urol. Nephrol. 44, 601-606 (2011
86. Yilmaz, M. I. et al. Low triiodothyronine alters flow-mediated vasodilatation in advanced nondiabetic kidney disease. Am. J. Nephrol. 33, 25-32 (2010
87. Malyszko, J., Malyszko, J. S., Pawlak, K. & Mysliwiec, M. Thyroid function, endothelium, and inflammation in hemodialyzed patients: Possible relations? J. Ren. Nutr. 17, 30-37 (2007
88. Ojamaa, K., Klemperer, J. D. & Klein, I. Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 6, 505-512 (1996
89. Mizuno, I. et al. Upregulation of the klotho gene expression by thyroid hormone and during adipose differentiation in 3T3 L1 adipocytes. Life Sci. 68, 2917-2923 (2001
90. Sato, Y. et al. Thyroid hormone targets matrix Gla protein gene associated with vascular smooth muscle calcification. Circ. Res. 97, 550-557 (2005
91. Bommer, C. et al. d thyroxine reduces lipoprotein(a) serum concentration in dialysis patients. J. Am. Soc. Nephrol. 9, 90-96 (1998
92. Passino, C. et al. Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure. J. Card. Fail. 15, 35-40 (2009
93. Montenegro, J. et al. Changes in renal function in primary hypothyroidism. Am. J. Kidney Dis. 27, 195-198 (1996
94. Kreisman, S. H. & Hennessey, J. V. Consistent reversible elevations of serum creatinine levels in severe hypothyroidism. Arch. Intern. Med. 159, 79-82 (1999
95. Shin, D. H. et al. Preservation of renal function by thyroid hormone replacement therapy in chronic kidney disease patients with subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 97, 2732-2740 (2012
96. Shin, D. H. et al. Thyroid hormone replacement therapy attenuates the decline of renal function in chronic kidney disease patients with subclinical hypothyroidism. Thyroid 23, 654-661 (2013
97. Kimmel, M., Braun, N. & Alscher, M. D. Influence of thyroid function on different kidney function tests. Kidney Blood Press. Res. 35, 9-17 (2012
98. Villabona, C. et al. Blood volumes and renal function in overt and subclinical primary hypothyroidism. Am. J. Med. Sci. 318, 277-280 (1999
99. Hlad, C. J. Jr & Bricker, N. S. Renal function and I131 clearance in hyperthyroidism and myxedema. J. Clin. Endocrinol. Metab. 14, 1539-1550 (1954
100. Karanikas, G. et al. Isotopic renal function studies in severe hypothyroidism and after thyroid hormone replacement therapy. Am. J. Nephrol. 24, 41-45 (2004
101. Gillum, D. M., Falk, S. A., Hammond, W. S. & Conger, J. D. Glomerular dynamics in the hypothyroid rat and the role of the renin-angiotensin system. Am. J. Physiol. 253, F170-F179 (1987
102. Allon, M., Harrow, A., Pasque, C. B. & Rodriguez, M. Renal sodium and water handling in hypothyroid patients: The role of renal insufficiency. J. Am. Soc. Nephrol. 1, 205-210 (1990
103. Vargas, F. et al. Vascular and renal function in experimental thyroid disorders. Eur. J. Endocrinol. 154, 197-212 (2006
104. Moreno, J. M. et al. Role of endothelium-derived relaxing factors in the renal response to vasoactive agents in hypothyroid rats. Am. J. Physiol. Endocrinol. Metab. 285, E182-E188 (2003
105. Miell, J. P. et al. Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone and IGF-binding proteins. J. Clin. Endocrinol. Metab. 76, 950-955 (1993
106. Davis, R. G., Madsen, K. M., Fregly, M. J. & Tisher, C. C. Kidney structure in hypothyroidism. Am. J. Pathol. 113, 41-49 (1983
107. Salomon, M. I. et al. Renal lesions in hypothyroidism: A study based on kidney biopsies. Metabolism 16, 846-852 (1967
108. Mariani, L. H. & Berns, J. S. The renal manifestations of thyroid disease. J. Am. Soc. Nephrol. 23, 22-26 (2012
109. McDonough, A. A. et al. Thyroid hormone coordinately regulates Na+ K+-ATPase α and β-subunit mRNA levels in kidney. Am. J. Physiol. 254, C323-C329 (1988
110. Cadnapaphornchai, M. A. et al. Urinary concentrating defect in hypothyroid rats: Role of sodium, potassium, 2 chloride co-transporter, and aquaporins. J. Am. Soc. Nephrol. 14, 566-574 (2003
111. Chou, K. M. et al. Correlation of clinical changes with regard to thyroxine replacement therapy in hypothyroid patients - focusing on the change of renal function. Kidney Blood Press. Res. 34, 365-372 (2011
112. Reinhardt, W. et al. Triiodothyronine (T3) reflects renal graft function after renal transplantation. Clin. Endocrinol. (Oxf.) 46, 563-569 (1997
113. Junik, R. et al. Function, structure, and volume of thyroid gland following allogenic kidney transplantation. Transplant. Proc. 35, 2224-2226 (2003
114. Thomas, M. C., Mathew, T. H. & Russ, G. R. Changes in thyroxine requirements in patients with hypothyroidism undergoing renal transplantation. Am. J. Kidney Dis. 39, 354-357 (2002
115. Rosolowska-Huszcz, D., Kozlowska, L. & Rydzewski, A. Influence of low protein diet on nonthyroidal illness syndrome in chronic renal failure. Endocrine 27, 283-288 (2005
116. Utas, C. et al. Improvement of thyroid hormone profile and thyrotrophin (TSH) surge alterations in hemodialysis patients on erythropoietin treatment. Clin. Nephrol. 55, 471-476 (2001
117. Disthabanchong, S. & Treeruttanawanich, A. Oral sodium bicarbonate improves thyroid function in predialysis chronic kidney disease. Am. J. Nephrol. 32, 549-556 (2010
118. Sutter, P. M. et al. Beneficial effect of thyroxin in the treatment of ischemic acute renal failure. Pediatr. Nephrol. 2, 1-7 (1988
119. Siegel, N. J. et al. Beneficial effect of thyroxin on recovery from toxic acute renal failure. Kidney Int. 25, 906-911 (1984
120. Michael, U. F., Logan, J. L. & Meeks, L. A. The beneficial effects of thyroxine on nephrotoxic acute renal failure in the rat. J. Am. Soc. Nephrol. 1, 1236-1240 (1991
121. Acker, C. G. et al. A trial of thyroxine in acute renal failure. Kidney Int. 57, 293-298 (2000
122. De Groot, L. J. Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit. Care Clin. 22, 57-86 (2006
123. Harris, A. R., Fang, S. L., Vagenakis, A. G. & Braverman, L. E. Effect of starvation, nutriment replacement, and hypothyroidism on in vitro hepatic T4 to T3 conversion in the rat. Metabolism 27, 1680-1690 (1978
124. Escobar-Morreale, H. F., del Rey, F. E., Obregon, M. J. & de Escobar, G. M. Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat. Endocrinology 137, 2490-2502 (1996
125. Straub, E. Effects of l thyroxine in acute renal failure. Res. Exp. Med. (Berl.) 168, 81-87 (1976
126. Adamovich, K., Baranyai, Z., Guignard, J. P. & Sulyok, E. Effect of thyroxine administration on renal functions in newborn infants with perinatal asphyxia. Acta Paediatr. Hung. 32, 219-233 (1992
127. Lim, V. S., Flanigan, M. J., Zavala, D. C. & Freeman, R. M. Protective adaptation of low serum triiodothyronine in patients with chronic renal failure. Kidney Int. 28, 541-549 (1985
128. Lim, V. S., Tsalikian, E. & Flanigan, M. J. Augmentation of protein degradation by l triiodothyronine in uremia. Metabolism 38, 1210-1215 (1989
129. Carter, J. N., Eastman, C. J., Corcoran, J. M. & Lazarus, L. Effects of triiodothyronine administration in patients with chronic renal failure. Aust. N. Z. J. Med. 7, 612-616 (1977
130. Acker, C. G. et al. Thyroid hormone in the treatment of post-transplant acute tubular necrosis (ATN). Am. J. Transplant. 2, 57-61 (2002
131. Celikyurt, U. et al. Effect of cardiac resynchronization therapy on thyroid function. Clin. Cardiol. 34, 703-705 (2011
132. D'Aloia, A. et al. Effect of short-term infusive dobutamine therapy on thyroid hormone profile and hemodynamic parameters in patients with acute worsening heart failure and low-triiodothyronine syndrome. J. Investig. Med. 60, 907-910 (2012
133. Hamilton, M. A. et al. Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. Am. J. Cardiol. 81, 443-447 (1998
134. Pingitore, A. et al. Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low T3 syndrome: A randomized, placebo-controlled study. J. Clin. Endocrinol. Metab. 93, 1351-1358 (2008
135. Iervasi, G. et al. in Proceedings of the 2nd International Congress on Heart Disease - New Trends in Research, Diagnosis and Treatment (ed. Kimchi, A.) 549-553 (Medimond Medical Publications, 2001
136. Moruzzi, P. et al. Usefulness of l thyroxine to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy. Am. J. Cardiol. 73, 374-378 (1994
137. Moruzzi, P., Doria, E. & Agostoni, P. G. Medium-term effectiveness of l thyroxine treatment in idiopathic dilated cardiomyopathy. Am. J. Med. 101, 461-467 (1996
138. Malik, F. S. et al. Intravenous thyroid hormone supplementation in heart failure with cardiogenic shock. J. Card. Fail. 5, 31-37 (1999
139. Goldman, S. et al. DITPA (3, 5-diiodothyropropionic acid), a thyroid hormone analog to treat heart failure: Phase II trial veterans affairs cooperative study. Circulation 119, 3093-3100 (2009
140. Morkin, E. et al. Pilot studies on the use of 3, 5-diiodothyropropionic acid, a thyroid hormone analog, in the treatment of congestive heart failure. Cardiology 97, 218-225 (2002
141. Talukder, M. A. et al. Detrimental effects of thyroid hormone analog DITPA in the mouse heart: Increased mortality with in vivo acute myocardial ischemia-reperfusion. Am. J. Physiol. Heart Circ. Physiol. 300, H702-H711 (2011
142. The coronary drug project research group. The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. JAMA 220, 996-1008 (1972
143. [No authors listed] Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. Arch. Intern. Med. 148, 36-69 (1988
144. Kaptein, E. M., Sanchez, A., Beale, E. & Chan, L. S. Clinical review: Thyroid hormone therapy for postoperative nonthyroidal illnesses: A systematic review and synthesis. J. Clin. Endocrinol. Metab. 95, 4526-4534 (2010
145. Biondi, B. et al. Endothelial-mediated coronary flow reserve in patients with mild thyroid hormone deficiency. Eur. J. Endocrinol. 161, 323-329 (2009
146. Sawin, C. T. et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N. Engl. J. Med. 331, 1249-1252 (1994
147. Rosner, M H. & Bolton, W. K. The mortality risk associated with higher hemoglobin: Is the therapy to blame? Kidney Int. 74, 695-697 (2008
148. Baxter, J. D. & Webb, P. Thyroid hormone mimetics: Potential applications in atherosclerosis, obesity and type 2 diabetes. Nat. Rev. Drug Discov. 8, 308-320 (2009
149. Van den Berghe, G. et al. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J. Clin. Endocrinol. Metab. 84, 1311-1323 (1999
150. Chopra, I. J., Solomon, D. H., Hepner, G. W. & Morgenstein, A. A. Misleadingly low free thyroxine index and usefulness of reverse triiodothyronine measurement in nonthyroidal illnesses. Ann. Intern. Med. 90, 905-912 (1979
151. Surks, M. I. et al. Subclinical thyroid disease: Scientific review and guidelines for diagnosis and management. JAMA 291, 228-238 (2004
152. Monzani, F. et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: A double-blind, placebo-controlled study. J. Clin. Endocrinol. Metab. 89, 2099-2106 (2004